Vascular Solutions Financial Ratios

Vascular Solutions Inc -- USA Stock  

USD 56  0.00  0.00%

Use fundamental data analysis to confirm all available indicators of Vascular Solutions Inc to find out if markets are presently mispricing the corporation. We found thirty available drivers for Vascular Solutions Inc which can be compared to its competition. To make sure the equity is not overpriced, please validate all Vascular Solutions fundamentals including its Debt to Equity, and the relationship between Net Income and Number of Employees . Given that Vascular Solutions Inc has Number of Shares Shorted of 982.09 K, we advise you double-check Vascular Solutions Inc current market performance to make sure the company can sustain itself down the road.Use Vascular Solutions to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of Vascular Solutions to be traded at $55.44 in 30 days

Vascular Solutions Inc Valuation Over Time

Enterprise Value

Vascular Solutions Company Summary

Vascular Solutions competes with Edwards Lifesciences, Digirad, and DarioHealth Corp. Vascular Solutions Incs primary solutions include GuideLiner guide extension catheter device for use in complex interventions Pronto extraction catheters for treating acute myocardial infarction vein catheter reprocessing service for the radiofrequency vein ablation catheter and microintroducer kits that are used to gain percutaneous access to the vasculature to perform minimally invasive procedures. Its solutions also comprise hemostatic patches consisting of blood clotting products such as the DStat Dry hemostat a topical thrombinbased pad with a bandage used to control surface bleeding radial access products including the Accumed wrist positioning splints and Vasc Band inflatable compression bands Langston catheter used for the measurement of intravascular pressure gradients primarily to diagnose aortic valve stenosis and DStat Flowable hemostat that is used to control active bleeding. Vascular Solutions Inc sells its solutions through direct sales force and distributor to interventional cardiologists interventional radiologists electrophysiologists and vein specialists. Vascular Solutions Inc. was founded in 1996 and is headquartered in Minneapolis Minnesota.

Vascular Solutions Current Valuation vs Shares Owned by Institutions

Vascular Solutions Inc is rated first in current valuation category among related companies. It is rated first in shares owned by institutions category among related companies . The ratio of Current Valuation to Shares Owned by Institutions for Vascular Solutions Inc is about  12,772,888 

Vascular Solutions Fundamentals

    
 Better Than Average     
    
 Worse Than Average Compare Vascular Solutions to competition
FundamentalsVascular SolutionsPeer Average
Return On Asset6.28 % (15.64) %
Profit Margin7.59 % (5.5) %
Operating Margin9.41 % (10.91) %
Current Valuation937.53 M152.14 B
Shares Outstanding17.57 M1.43 B
Shares Owned by Insiders3.98 % 6.91 %
Shares Owned by Institutions73.4 % 18.37 %
Number of Shares Shorted982.09 K3.24 M
Price to Earning81.18 times40.69 times
Price to Book6.86 times14.44 times
Price to Sales6.1 times17.81 times
Revenue160 M9.85 B
Gross Profit98.3 M21.75 B
Net Income12.14 M517.71 M
Cash and Equivalents39.07 M3.89 B
Cash per Share2.23 times5.17 times
Total Debt867 K7.36 B
Debt to Equity0.13 % 0.72 %
Current Ratio6.37 times3.3 times
Cash Flow from Operations13.03 M1.25 B
Earnings Per Share0.69 times2.3 times
Number of Employees56810.67 K
Beta1.060.34
Total Asset156.6 M126.86 B
Retained Earnings27.03 M38.24 B
Working Capital75.79 M3.58 B
Current Asset89.91 M36.8 B
Current Liabilities14.12 M33.34 B
Z Score1.0708.73
< 45% 

Chance of Financial Distress

Vascular Solutions Inc has less than 45 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
Details

Growth

Vascular Solutions Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth

Compare

Compare Vascular Solutions To Peers
Howard Root Co-Founder, CEO and Director
John Erb Independent Chairman of the Board
More Executives

Opportunity Range

October 23, 2017 Opportunity Range